Literature DB >> 19085810

Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria.

D Tews1, S Lehr, S Hartwig, A Osmers, W Paslack, J Eckel.   

Abstract

Glucagon like peptide-1 (Glp-1) exhibits beneficial effects on beta cell mass by both enhancing proliferation and inhibiting apoptosis. The precise mechanism of the anti-apoptotic effect of Glp-1 and Glp-1 mimetics like exendin-4 has remained elusive. Here, we studied cytokine-induced apoptosis in the pancreatic beta cell line INS-1 and performed a comparative mitochondrial protein pattern analysis using two-dimensional difference gel electrophoresis (2D-DIGE). Cytokine incubation of INS-1 cells increased caspase-3 activity about 3-fold, which was reduced by 60% in the presence of exendin-4. Production of reactive oxygen species in response to cytokines was completely prevented after preincubation with exendin-4. Highly purified mitochondria were obtained and mitochondrial proteins were labeled with Cy-dyes and separated on overlapping zoom 2D gels spanning a pH-range of 4-9. Protein spots with significant changes after cytokine and exendin-4 treatment were identified by MALDI mass spectrometry. Comparing all treatment conditions, comparative mitochondrial proteome analysis allowed to identify 33 different proteins, which were significantly altered between comparison groups. Changes in protein patterns revealed involvement of cytokine-induced electron transport chain damage. Thus, cytochrome bc1 complex subunit I and ATP synthase subunit beta were downregulated by 30-40%. This was abrogated by the presence of exendin-4. In conclusion, this study provides further insights into the role of mitochondria in cytokine-induced apoptosis. We show here that exendin-4 significantly counter-regulates the reduced abundance of electron transport chain proteins, leading to a reduction of oxidative stress and most likely contributing to the anti-apoptotic action of this drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085810     DOI: 10.1055/s-0028-1105911

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  14 in total

1.  A noncytolytic antibody-like extendin-4-IgG4 fusion protein as a long-acting potential anti-diabetic agent.

Authors:  Xiaoxia Li; Pinliang Hu; Rungong Yang; Jie Bai; Xingheng Wang; Shuhong Fu; Siyi Yang; Jinwei Ma; Meiliang Gong; Hong Chen; Feng Zhou; Yanbing Chen; Qian Zhou
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

3.  The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.

Authors:  M Shimoda; Y Kanda; S Hamamoto; K Tawaramoto; M Hashiramoto; M Matsuki; K Kaku
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

Review 4.  Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.

Authors:  Alexander Harkavyi; Peter S Whitton
Journal:  Br J Pharmacol       Date:  2010-01-29       Impact factor: 8.739

5.  Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats.

Authors:  Elisabeth L Raab; Patricia M Vuguin; Doris A Stoffers; Rebecca A Simmons
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-21       Impact factor: 3.619

6.  Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.

Authors:  Yi Zhan; Hui-lin Sun; Hong Chen; Hua Zhang; Jia Sun; Zhen Zhang; De-hong Cai
Journal:  Med Sci Monit       Date:  2012-07

7.  Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals.

Authors:  Catarina Marques; Cristina Mega; Andreia Gonçalves; Paulo Rodrigues-Santos; Edite Teixeira-Lemos; Frederico Teixeira; Carlos Fontes-Ribeiro; Flávio Reis; Rosa Fernandes
Journal:  Mediators Inflamm       Date:  2014-04-08       Impact factor: 4.711

8.  Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation.

Authors:  Tien-Jyun Chang; Hsing-Chi Tseng; Meng-Wei Liu; Yi-Cheng Chang; Meng-Lun Hsieh; Lee-Ming Chuang
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

9.  Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue.

Authors:  Megu Yamaguchi Baden; Kenji Fukui; Yoshiya Hosokawa; Hiromi Iwahashi; Akihisa Imagawa; Iichiro Shimomura
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

Review 10.  Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies.

Authors:  Karen Ekkelund Petersen; Günaj Rakipovski; Kirsten Raun; Jens Lykkesfeldt
Journal:  Curr Diabetes Rev       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.